Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga

Antiviral therapeutics with existing clinical safety profiles would be highly desirable in an outbreak situation, such as the 2013–2016 emergence of Ebola virus (EBOV) in West Africa. Although, the World Health Organization declared the end of the outbreak early 2016, sporadic cases of EBOV infectio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Chiramel, Abhilash I., Banadyga, Logan, Dougherty, Jonathan D., Falzarano, Darryl, Martellaro, Cynthia, Brees, Dominique, Taylor, R. Travis, Ebihara, Hideki, Best, Sonja M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Ebola Outbreak in West Africa
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5050471/
https://ncbi.nlm.nih.gov/pubmed/27511894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw241
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi